Table of Contents:
  • The need to characterise SARS-CoV-2-specific T-cells from recovered patients
  • Discovery of similar SARS-CoV-2-specific T-cells in healthy volunteers
  • Possible reasons for presence of SARS-2-specific T-cells in healthy volunteers
  • Differences in actions and behaviours of SARS-2-specific T-cells in patients versus volunteers
  • Role of SARS-2-specific T-cells in conferring pre-existing immunity to COVID-19 (i.e. asymptomatic infections)
  • Possible implications of the presence of such cells on disease progression
  • Implications for vaccine development